Alopecia Androgenic

Androgenetic alopecia

CordermaPRP® increases the hair density of patients treated for androgenetic alopecia.
In a prospective study1, 20 patients were treated with CordermaPRP® intradermal injections for androgenetic alopecia.

Three treatment sessions were performed with an interval of 21 days and a booster session at 6 months following the onset of therapy.

Clinical benefits were evaluated in terms of hair density.

Conclusion

CordermaPRP® treatment restores hair loss to normal levels.

CordermaPRP® can be used in combination with other hair restoration modalities (minoxidil, finasteride).
In a retrospective study, Ho et al.2 evaluated 24 patients receiving injections of CordermaPRP. All study patients used topical 5% minoxidil and 83.3% (20/24) used oral antiandrogen medications. The treatment consisted of a monthly injection of PRP for 6 months followed by injections every 3-6 months. Mean trichoscopic measurements throughout the treatment course (average 6 months; range 2-24 months) were compared to baseline measures.

Conclusion

CordermaPRP® promotes the Cordermaeration of the hair bulb by increasing the blood supply and enhancing follicular cell proliferation, resulting in stronger, denser, and richer hair.